JP Patent

JP4290381B2 — ピリドンカルボン酸化合物含有エマルション

Assigned to LTT Bio Pharma Co Ltd · Expires 2009-07-01 · 17y expired

What this patent protects

Patent listed against delafloxacin-meglumine.

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: JP4290381B2
Jurisdiction: JP
Classification: —
Expires: 2009-07-01
Drug substance claim: No
Drug product claim: No
Assignee: LTT Bio Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.